319 related articles for article (PubMed ID: 23969223)
1. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention.
Ndrepepa G; Braun S; Cassese S; Fusaro M; King L; Kastrati A; Schmidt R
Cardiovasc Revasc Med; 2013; 14(5):264-9. PubMed ID: 23969223
[TBL] [Abstract][Full Text] [Related]
2. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
[TBL] [Abstract][Full Text] [Related]
3. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
4. A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease.
Ndrepepa G; Cassese S; Braun S; Fusaro M; King L; Tada T; Schömig A; Kastrati A; Schmidt R
Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1195-201. PubMed ID: 24099726
[TBL] [Abstract][Full Text] [Related]
5. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
Herrmann J; Lennon RJ; Barsness GW; Sandhu GS; Gulati R; Best PJ; Sorajja P; Bresnahan JF; Mathew V; Bell MR; Prasad A
Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
[TBL] [Abstract][Full Text] [Related]
6. Correlates of poor outcome among patients with bleeding after coronary interventions.
Ndrepepa G; Guerra E; Schulz S; Hoppmann P; Laugwitz KL; Kastrati A
Coron Artery Dis; 2014 Sep; 25(6):456-62. PubMed ID: 24801558
[TBL] [Abstract][Full Text] [Related]
7. High-sensitive C-reactive protein predicts outcome after coronary artery bypass.
Wang J; Zheng Z; Yang L; Zhang L; Fan H; Hu S
Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):525-33. PubMed ID: 23087294
[TBL] [Abstract][Full Text] [Related]
8. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
[TBL] [Abstract][Full Text] [Related]
9. High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention.
Bjerre M; Pedersen SH; Møgelvang R; Lindberg S; Jensen JS; Galatius S; Flyvbjerg A
Eur J Prev Cardiol; 2013 Dec; 20(6):922-9. PubMed ID: 23613225
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of a randomized, controlled clinical trial of three therapeutic strategies for multivessel stable coronary artery disease in women.
Mansur Ade P; Hueb WA; Takada JY; Avakian SD; Soares PR; Garzilo CL; Kalil Filho R; Ramires JA
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):997-1001. PubMed ID: 25183741
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value.
Scognamiglio G; Kempny A; Price LC; Alonso-Gonzalez R; Marino P; Swan L; D' Alto M; Hooper J; Gatzoulis MA; Dimopoulos K; Wort SJ
Heart; 2014 Sep; 100(17):1335-41. PubMed ID: 24790070
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
15. Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index.
Généreux P; Campos CM; Yadav M; Palmerini T; Caixeta A; Xu K; Francese DP; Dangas GD; Mehran R; Leon MB; Serruys PW; Stone GW
EuroIntervention; 2015 Oct; 11(6):634-42. PubMed ID: 25308300
[TBL] [Abstract][Full Text] [Related]
16. Association of uric acid with mortality in patients with stable coronary artery disease.
Ndrepepa G; Braun S; King L; Hadamitzky M; Haase HU; Birkmeier KA; Schömig A; Kastrati A
Metabolism; 2012 Dec; 61(12):1780-6. PubMed ID: 22749121
[TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria in non-diabetic STEMI: an independent predictor for acute kidney injury.
Lazzeri C; Valente S; Chiostri M; Picariello C; Attanà P; Gensini GF
Scand Cardiovasc J; 2012 Dec; 46(6):324-9. PubMed ID: 22694718
[TBL] [Abstract][Full Text] [Related]
18. Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials.
Iijima R; Byrne RA; Ndrepepa G; Braun S; Mehilli J; Berger PB; Schömig A; Kastrati A
Heart; 2009 Feb; 95(2):107-12. PubMed ID: 18801777
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
20. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes.
Frasure-Smith N; Lespérance F; Irwin MR; Sauvé C; Lespérance J; Théroux P
Biol Psychiatry; 2007 Aug; 62(4):302-8. PubMed ID: 17210140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]